10-K: Ascend Wellness Holdings Reports 2023 Financial Results, Highlights Expansion and Strategic Growth
Annual Results
Ascend Wellness Holdings reports a 28% increase in revenue for 2023, driven by acquisitions and new store openings, while also reducing its operating loss.
Summary
- Ascend Wellness Holdings (AWH) reported a 28% increase in revenue for 2023, reaching $518.6 million, compared to $405.9 million in 2022.
- The revenue growth was primarily driven by acquisitions, including Devi Maryland, and new dispensary openings, partially offset by declines in some legacy locations due to increased competition.
- Wholesale revenue grew by $47.4 million, supported by increased production at the New Jersey facility and higher sales volumes in New Jersey, Massachusetts, and Illinois.
- The company sold approximately 145,000 pounds of wholesale product in 2023, compared to 68,000 pounds in 2022.
- AWH's operating loss decreased by 52% to $3.6 million in 2023, compared to $7.5 million in 2022, due to leveraging existing infrastructure and improved overhead utilization.
- The net loss for 2023 was $48.2 million, a 40% decrease from the $80.9 million loss in 2022.
- As of December 31, 2023, AWH had 34 open dispensaries and 245,000 square feet of cultivation canopy.
- The company plans to expand to 39 open dispensaries by the end of 2024.
- AWH generated $75.3 million in net cash from operating activities in 2023, compared to a net cash used in operating activities of $38.4 million in 2022.
Sentiment
Score: 7
Explanation: The document presents a generally positive outlook with strong revenue growth and improved operational efficiency. However, the company still faces challenges, including pricing pressure and regulatory risks, which temper the overall sentiment.
Positives
- AWH achieved significant revenue growth, driven by strategic acquisitions and new store openings.
- The company demonstrated improved operational efficiency, leading to a substantial reduction in operating losses.
- AWH's wholesale business experienced strong growth, with a significant increase in sales volume.
- The company is expanding its retail footprint, with plans to reach 39 open dispensaries by the end of 2024.
- AWH generated positive cash flow from operations in 2023, indicating improved financial health.
Negatives
- AWH experienced pricing pressure in certain markets, which negatively impacted gross margins.
- The company incurred higher compensation expenses, including certain contract termination payments.
- AWH recorded write-downs of certain inventory items, impacting gross profit.
- The company continues to operate at a net loss, although the loss has decreased compared to the previous year.
Risks
- The cannabis industry remains subject to regulatory uncertainty, including the risk of federal enforcement.
- AWH faces competition from other multi-state operators and single-state operators.
- The company's operations are subject to security risks, including theft and cyber-attacks.
- AWH may face difficulties in enforcing contracts due to the federal illegality of cannabis.
- The company's ability to access banking and financial services is restricted due to federal regulations.
- AWH is subject to the risk of product liability claims and other litigation.
- The company's ability to utilize net operating loss carryforwards may be limited.
- AWH is subject to the risk of adverse changes in wholesale and retail prices.
- The company is subject to the risk of sustained inflation and political and economic instability.
Future Outlook
AWH anticipates continued growth driven by new operational facilities and dispensaries, expansion of current facilities, and increased consumer demand. The company expects to have 39 open dispensaries by the end of 2024. Expansion plans are subject to capital allocation decisions, the evolving regulatory environment, and general economic factors.
Management Comments
- AWH believes in bettering lives through cannabis.
- The company's mission is to improve the lives of its employees, patients, customers, and the communities they serve through the use of the cannabis plant.
- AWH is committed to being vertically integrated in every state it operates in.
Industry Context
The announcement reflects the ongoing growth and consolidation trends in the cannabis industry, with companies focusing on expansion through acquisitions and strategic partnerships. AWH's focus on limited-license markets aligns with a common strategy to establish a strong presence in states with higher barriers to entry. The company's emphasis on vertical integration is also a common strategy to control the supply chain and improve margins.
Comparison to Industry Standards
- AWH's revenue growth of 28% is comparable to other multi-state operators in the cannabis industry, although specific growth rates vary depending on the company's focus and market presence.
- The company's operating loss reduction of 52% is a positive sign, indicating improved operational efficiency, which is a key focus for many cannabis companies.
- AWH's gross margin of 29.9% is lower than some of its peers, which may be due to pricing pressure in certain markets. Companies like Trulieve and Curaleaf have reported higher gross margins, but these vary based on market conditions and product mix.
- The company's focus on vertical integration is a common strategy among multi-state operators, with companies like Green Thumb Industries and Cresco Labs also emphasizing this approach.
- AWH's expansion plans to reach 39 dispensaries by the end of 2024 are in line with the growth strategies of other multi-state operators, although the pace of expansion varies among companies.
Legal Proceedings
- The Company is involved in ongoing litigation with MedMen related to a terminated investment agreement.
- The Company is pursuing collection of amounts due under a working capital loan agreement with MedMen NY, Inc.
Related Party Transactions
- The Company has a loan receivable from a borrower that is partially owned by an entity that is managed, in part, by one of the founders of the Company.
Stakeholder Impact
- Shareholders may benefit from the company's revenue growth and improved profitability.
- Employees may benefit from the company's expansion and growth opportunities.
- Customers may benefit from the company's expanded product offerings and retail locations.
- Suppliers may benefit from the company's increased demand for products and services.
- Creditors may benefit from the company's improved financial health and ability to meet its obligations.
Next Steps
- The company plans to expand to 39 open dispensaries by the end of 2024.
- AWH intends to continue to access capital markets for additional funding through debt and/or equity financings to supplement future cash needs.
- The company will continue to pursue strategic initiatives to expand its operations and market presence.
Key Dates
| Date | Description |
|---|---|
| May 15, 2018 | The Company was originally formed as Ascend Group Partners, LLC. |
| September 10, 2018 | The Company changed its name to Ascend Wellness Holdings, LLC. |
| April 22, 2021 | Ascend Wellness Holdings, LLC converted into a Delaware corporation and changed its name to Ascend Wellness Holdings, Inc. |
| May 4, 2021 | The Company completed its Initial Public Offering (IPO). |
| August 27, 2021 | The Company entered into a credit agreement for a $210 million term loan. |
| August 12, 2022 | The Company entered into a definitive agreement to acquire Ohio Patient Access, LLC. |
| November 22, 2022 | The Company filed a registration statement on Form S-3. |
| December 22, 2022 | The Registration Statement became effective. |
| April 27, 2023 | The Company acquired Devi Holdings, Inc. in Maryland. |
| January 2024 | The Company entered into a definitive agreement to acquire a cultivation and a manufacturer license in Massachusetts. |
| March 1, 2024 | The Company had a total of 35 dispensaries. |
Keywords
cannabis, multi-state operator, dispensaries, cultivation, wholesale, acquisitions, revenue, profitability, vertical integration, limited license markets
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.